Pfizer News News 14 December 2025

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

NEW YORK, December 31, 2025, 08:51 ET — Premarket Pfizer Inc shares were little changed in premarket trading on Wednesday after a report showed the drugmaker is leading a new round of U.S. list-price increases for 2026. The stock was

31 December 2025

Drug Pricing·Healthcare Industry·Pfizer News·Pharmaceuticals·Stock Market

Pfizer stock today: PFE holds near $25 as year-end trading turns to Fed minutes and next earnings

NEW YORK, December 30, 2025, 03:31 ET — Market closed Pfizer Inc (PFE) shares were last down 0.3% at $25.00 in after-hours trading, after ending Monday at $25.09. The stock traded between $24.98 and $25.19 in the regular session. With

30 December 2025

Earnings Reports·Federal Reserve·Investing·Pfizer News·Stock Market

Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

NEW YORK, December 29, 2025, 2:08 PM ET — Regular session Pfizer shares dipped slightly on Monday, trading down about 0.1% at $25.06 as of 2:08 p.m. ET. The stock has moved between $24.99 and $25.19 in the regular session.

29 December 2025

Earnings Reports·Financial Analysis·Investing·Pfizer News·Stock Market

Pfizer Stock (NYSE: PFE) Holds Near $25 as Markets Close for the Weekend: Latest News, Analyst Targets, and What to Watch Monday

NEW YORK, Dec. 28, 2025, 2:50 p.m. ET — U.S. stock market closed (Sunday). Pfizer Inc. (NYSE: PFE) heads into the final week of 2025 with its shares hovering in the mid-$20s — a level Wall Street has increasingly framed

28 December 2025

Analyst Insights·Financial Updates·Investment Tips·Pfizer News·Stock Market

Pfizer Stock (PFE) Update: Shares Hold Near $25 Into Year-End as Investors Weigh 2026 Guidance, Dividend, and Pipeline Catalysts

NEW YORK, Dec. 27, 2025, 3:07 p.m. ET — Market closed Pfizer Inc. (NYSE: PFE) is heading into the final trading days of 2025 with its stock still anchored in the mid-$20s, a range that has increasingly defined sentiment around

27 December 2025

Dividend Stocks·Investment Strategies·Pfizer News·Pharmaceutical Industry·Stock Market

Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer Inc. (NYSE: PFE) heads into Christmas Day with investors digesting a dense run of December headlines: a 2026 outlook that came in below Wall Street expectations, ongoing restructuring and cost-cutting, fresh U.S. drug-pricing initiatives that could reshape the industry’s

25 December 2025

Analyst Opinions·Financial Forecasts·Investment Analysis·Pfizer News·Stock Market

Pfizer Stock (PFE) Forecast and News: 2026 Guidance, Drug-Pricing Deals, and Pipeline Catalysts to Watch on Dec. 19, 2025

Pfizer Inc. (NYSE: PFE) stock was essentially flat on Friday, Dec. 19, 2025, trading around $25.04 in midday trading, after a volatile week that blended policy headlines, a reset of near-term financial expectations, and fresh pipeline updates. For investors, the

19 December 2025

Investment Analysis·Market Forecasts·Pfizer News·Pharmaceutical Industry·Stock Market

Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Inc. (NYSE: PFE) stock is trying to steady itself in late December after a volatile stretch driven by one big theme: the post-COVID hangover is still real, and 2026 is shaping up as another “rebuild” year—even as Pfizer spends

18 December 2025

Dividend Stocks·Investment Analysis·Pfizer News·Price Forecasts·Stock Market

Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday

Pfizer (NYSE: PFE) finished Wednesday’s session lower and traded only modestly in the after-hours market—an indication that investors are still digesting the company’s newly issued 2026 outlook while weighing fresh pipeline headlines and looming U.S. policy risk around drug pricing.

18 December 2025

After Hours Trading·Financial Analysis·Investing Tips·Pfizer News·Stock Market

Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Inc. stock (NYSE: PFE) is back in the spotlight on Wednesday, December 17, 2025, as investors digest the drugmaker’s newly issued 2026 outlook, a revised 2025 revenue view, and a longer runway to sustained growth than some shareholders had

17 December 2025

Financial Forecasts·Investment Analysis·Pfizer News·Stock Market

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

December 17, 2025 Pfizer Inc. (NYSE: PFE) stock is back in the spotlight on December 17 as investors digest the company’s newly issued full-year 2026 financial guidance, along with a stack of fresh reporting and analyst commentary about what comes

17 December 2025

Earnings Reports·Financial Forecasts·Investment Analysis·Pfizer News·Stock Market

Pfizer Stock (PFE) Before Market Open Dec. 15, 2025: Key News, 2026 Guidance Call, Analyst Targets, Dividend, and Risks

Pfizer (NYSE: PFE) heads into Monday’s U.S. market open (Dec. 15, 2025) in a familiar spot for late 2025: investors are weighing a high dividend and aggressive deal-making against policy uncertainty for COVID vaccines and the company’s ongoing push to

14 December 2025

Dividend Updates·Investment Analysis·Pfizer News·Stock Market

Pfizer News News 14 December 2025 - 31 December 2025